Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Lira 85, 5º Piso, Santiago, Chile.
Pituitary. 2012 Mar;15(1):93-6. doi: 10.1007/s11102-010-0219-6.
Primary pituitary lymphoma in immunocompetent patients is a rare disease and has been described in less than 20 cases. Moreover, low-grade lymphomas constitute only 3% of all primary central nervous system lymphoma. The objective of this report is to report a low-grade primary pituitary lymphoma, diagnostic problems and to give more evidence about the evolution of this rare disease. A 49 y.o. woman was referred to our clinic with symptoms of hypopituitarism. A diagnostic work-up showed mild anemia, an erythrocyte sedimentation rate of 122 mm/h and a negative Elisa test for HIV. Panhypopituitarism was confirmed and the MRI showed a 20 mm sellar and suprasellar enhancing mass with a thickening of the pituitary stalk, chiasmal compression and bitemporal hemianopsia. She underwent transsphenoidal resection only 10 months later for non medical reasons. During this period she was clinically asymptomatic on hormonal replacement therapy. A new MRI showed regression of the suprasellar extension and invasion to the left cavernous sinus. A firm and infiltrative mass was found during transsphenoidal surgery, and only partial resection was performed. Biopsy showed a low-grade lymphoplasmacytic lymphoma. Staging was negative for other localizations. She was given chemotherapy and localized radiotherapy. Four years after surgery, the sellar MRI showed a 10 mm residual sellar mass with the persistence of a cavernous sinus invasion and she is considered to be in remission. The neurosurgeon and clinician should consider primary pituitary lymphoma as a potential cause of a sellar mass, especially in the presence of diabetes insipidus and an enhancing invasive mass. Neurosurgical biopsy is crucial for a correct diagnosis and prognosis could be better than classic CNS primary lymphomas.
免疫功能正常患者的原发性垂体淋巴瘤较为罕见,文献报道不足 20 例。此外,低级别淋巴瘤仅占所有原发性中枢神经系统淋巴瘤的 3%。本报告的目的是报告一例低级别原发性垂体淋巴瘤,诊断问题,并提供更多关于这种罕见疾病演变的证据。一名 49 岁女性因垂体功能减退的症状就诊于我科。诊断性检查显示轻度贫血,红细胞沉降率为 122mm/h,HIV Elisa 检测阴性。明确诊断为全垂体功能减退症,MRI 显示鞍内和鞍上 20mm 强化肿块,伴有垂体柄增粗、视交叉受压和双眼颞侧偏盲。由于非医疗原因,她在 10 个月后才接受经蝶窦切除术。在此期间,她在激素替代治疗下临床无症状。新的 MRI 显示鞍上延伸和侵犯左侧海绵窦的部分消退。经蝶窦手术发现一坚硬浸润性肿块,仅行部分切除。活检显示低级别淋巴浆细胞淋巴瘤。分期检查未发现其他部位的转移。她接受了化疗和局部放疗。术后 4 年,鞍内 MRI 显示 10mm 残留鞍内肿块,仍有海绵窦侵犯,目前被认为处于缓解期。神经外科医生和临床医生应将原发性垂体淋巴瘤视为鞍内肿块的潜在原因,尤其是在存在尿崩症和侵袭性强化肿块的情况下。神经外科活检对明确诊断至关重要,且预后可能优于经典中枢神经系统原发性淋巴瘤。